Insiders Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Real-time Estimate Cboe BZX Other stock markets 13:39:21 2024-05-08 EDT			5-day change	1st Jan Change
4.375 ^USD	-4.06%		+12.53%	-12.18%

05-03	Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise	MT
04-23	Sector Update: Health Care Stocks Rise Late Afternoon	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Abeona Therapeutics Inc. Appoints Madhav Vasanthavada as Chief Commercial Officer	23-09-12	CI
Abeona Therapeutics Inc. Announces Management Changes	22-03-09	CI
Abeona Therapeutics Inc. Appoints Jon Voss as Vice President, Head of Quality	21-10-12	CI
Precision BioSciences : Names Michael Amoroso President, Chief Executive	21-09-27	MT
Abeona Therapeutics Inc. Announces Board and Management Changes	21-09-21	CI
Abeona Therapeutics : Names CEO, Chairman	21-09-21	MT
Abeona Therapeutics Inc. Appoints Dr. Vishwas Seshadri as Chief Executive Officer, Effective October 15, 2021	21-09-21	CI
Abeona Therapeutics Inc. Appoints Edward Carr as Senior Vice President	21-08-13	CI
Abeona Therapeutics Inc. Appoints Edward Carr as Principal Financial Officer	21-08-11	CI
Abeona Therapeutics Appoints Edward Carr as Chief Financial Officer	21-08-10	CI
Abeona Therapeutics Inc. Announces Board Committee Appointments	21-05-28	CI
Abeona Therapeutics Inc. Appoints Vishwas Seshadri as Senior Vice President, Head of Research & Clinical Development	21-05-25	CI
Abeona Therapeutics Inc. Announces Appointment of Michael Amoroso as President and a Member of the Company's Board of Directors	21-05-18	CI
Abeona Therapeutics Inc. Announces Board Appointments	21-04-19	CI
Abeona Therapeutics Inc. Appoints Faith Charles and Mark Alvino as Independent Members to Board of Directors	21-03-25	CI
Abeona Therapeutics Inc. Promotes Michael Amoroso to President and A Member of Board of Directors	21-03-22	CI
Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer	21-03-22	CI
Abeona Therapeutics Inc. Announces the Appointment of Michael Amoroso as Chief Operating Officer, with effect from November 01, 2020	20-10-27	CI
Abeona Therapeutics Inc. Announces Board Changes	20-10-06	CI
Abeona Therapeutics Inc. Announces Management Changes	20-09-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Insiders

Filters